These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1620 related items for PubMed ID: 19747632
21. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease. Lee S, Cho BS, Kim SY, Choi SM, Lee DG, Eom KS, Kim YJ, Kim HJ, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Shin WS, Kim CC. Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971 [Abstract] [Full Text] [Related]
22. Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials. Hermsen ED, Maiefski M, Florescu MC, Qiu F, Rupp ME. Pharmacotherapy; 2009 Jun; 29(6):649-55. PubMed ID: 19476418 [Abstract] [Full Text] [Related]
23. Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties. Uderzo C, Pillon M, Corti P, Tridello G, Tana F, Zintl F, Nysom K, Galambrun C, Fagioli F, Varotto S, Messina C, Verdeguer A, Urban C, Faraci M, Dini G, Fedeli S, Tichelli A, Rovelli A, Socié G. Bone Marrow Transplant; 2007 Jun; 39(11):667-75. PubMed ID: 17401396 [Abstract] [Full Text] [Related]
24. A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease. Akpek G, Lee SM, Anders V, Vogelsang GB. Biol Blood Marrow Transplant; 2001 Jun; 7(9):495-502. PubMed ID: 11669216 [Abstract] [Full Text] [Related]
25. Early renal injury after nonmyeloablative allogeneic peripheral blood stem cell transplantation in patients with chronic myelocytic leukemia. Liu H, Ding JH, Liu BC, Zhao G, Chen BA. Am J Nephrol; 2007 Jun; 27(4):336-41. PubMed ID: 17519537 [Abstract] [Full Text] [Related]
26. Ocular findings after allogeneic hematopoietic stem cell transplantation. Tabbara KF, Al-Ghamdi A, Al-Mohareb F, Ayas M, Chaudhri N, Al-Sharif F, Al-Zahrani H, Mohammed SY, Nassar A, Aljurf M. Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097 [Abstract] [Full Text] [Related]
27. Renal function in long-term survivors of stem cell transplantation in childhood. A prospective trial. Patzer L, Ringelmann F, Kentouche K, Fuchs D, Zintl F, Brandis M, Zimmerhackl LB, Misselwitz J. Bone Marrow Transplant; 2001 Feb; 27(3):319-27. PubMed ID: 11277181 [Abstract] [Full Text] [Related]
28. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia. Liu QF, Fan ZP, Zhang Y, Jiang ZJ, Wang CY, Xu D, Sun J, Xiao Y, Tan H. Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296 [Abstract] [Full Text] [Related]
29. Chronic kidney disease after heart transplantation. Hamour IM, Omar F, Lyster HS, Palmer A, Banner NR. Nephrol Dial Transplant; 2009 May; 24(5):1655-62. PubMed ID: 19168463 [Abstract] [Full Text] [Related]
30. Herpes zoster infection in the post-hematopoietic stem cell transplant pediatric population may be preceded by transaminitis: an institutional experience. Berman JN, Wang M, Berry W, Neuberg DS, Guinan EC. Bone Marrow Transplant; 2006 Jan; 37(1):73-80. PubMed ID: 16247423 [Abstract] [Full Text] [Related]
31. Favorable outcome of allogeneic hematopoietic stem cell transplantation for relapsed or refractory acute promyelocytic leukemia in childhood. Bourquin JP, Thornley I, Neuberg D, Brennan L, Kung A, Clark J, Lehmann L, Guinan EC. Bone Marrow Transplant; 2004 Nov; 34(9):795-8. PubMed ID: 15354207 [Abstract] [Full Text] [Related]
33. Risk factors for MDRD-GFR of less than 60 mL/min per 1.73 m2 in former kidney donors. Lee JH, Kim SC, Han DJ, Chang JW, Yang WS, Park SK, Lee SK, Park JS, Kim SB. Nephrology (Carlton); 2007 Dec; 12(6):600-6. PubMed ID: 17995588 [Abstract] [Full Text] [Related]
36. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies. Chen XH, Zhang C, Zhang X, Gao L, Gao L, Kong PY, Peng XG, Qi DG, Sun AH, Zeng DF, Liu H, Gong Y, Wang QY. Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687 [Abstract] [Full Text] [Related]
38. Immune reconstitution following myeloablative allogeneic hematopoietic stem cell transplantation: the impact of expanding CD28negative CD8+ T cells on relapse. Yakoub-Agha I, Saule P, Magro L, Cracco P, Duhamel A, Coiteux V, Bruno B, Dufossé F, Jouet JP, Dessaint JP, Labalette M. Biol Blood Marrow Transplant; 2009 Apr; 15(4):496-504. PubMed ID: 19285638 [Abstract] [Full Text] [Related]
39. Osteochondroma after hematopoietic stem cell transplantation in childhood. An Italian study on behalf of the AIEOP-HSCT group. Faraci M, Bagnasco F, Corti P, Messina C, Fagioli F, Podda M, Prete A, Caselli D, Lanino E, Dini G, Rondelli R, Haupt R, AIEOP-HSCT Group. Biol Blood Marrow Transplant; 2009 Oct; 15(10):1271-6. PubMed ID: 19747635 [Abstract] [Full Text] [Related]
40. High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation. Labbé AC, Su SH, Laverdière M, Pépin J, Patiño C, Cohen S, Kiss T, Lachance S, Sauvageau G, Busque L, Roy DC, Roy J. Biol Blood Marrow Transplant; 2007 Oct; 13(10):1192-200. PubMed ID: 17889356 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]